Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions

Revathy Guruswamy1,2, Ayman ElAli3,4

  • 1Neuroscience Axis, CHU de Québec Research Center (CHUL), Québec City, QC G1V 4G2, Canada. revathy.guruswamy.1@ulaval.ca.

Insights

Microglia, the brain's immune cells, have a dual role in ischemic stroke. They are detrimental in the acute phase but essential for tissue repair later, complicating immunomodulatory therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathobiology

Background:

  • Ischemic stroke is a leading cause of death and disability.
  • Neuroinflammation, driven by microglia, plays a critical role in stroke pathology.
  • Microglia, the brain's innate immune cells, act as sentinels for homeostasis.
  • Their activation leads to responses including debris clearance and inflammatory signaling.

Purpose of the Study:

  • To review the complex role of microglia and macrophages in ischemic stroke.
  • To explore the dual function of microglia in acute and post-acute stroke phases.
  • To highlight future directions for immunomodulatory therapeutic interventions.

Main Methods:

  • Literature review of scientific reports on microglia and ischemic stroke.
  • Analysis of the evolving understanding of microglial roles.
  • Identification of challenges and opportunities in immunomodulatory therapy development.

Main Results:

  • Microglia exhibit a complex, dual role in ischemic stroke.
  • Initially considered detrimental, microglia are now recognized as crucial for tissue regeneration post-stroke.
  • This complexity presents a challenge for developing effective immunomodulatory treatments.

Conclusions:

  • The multifaceted role of microglia in ischemic stroke necessitates nuanced therapeutic strategies.
  • Understanding the temporal dynamics of microglial activation is key for future interventions.
  • Targeting microglia and macrophages offers potential for novel stroke therapies.

Related Concept Videos